Cargando…

Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy

BACKGROUND: Although WD repeat and high-mobility group box DNA binding protein 1 (WDHD1) played an essential role in DNA replication, chromosome stability, and DNA damage repair, the panoramic picture of WDHD1 in human tumors remains unclear. Hence, this study aims to comprehensively characterize WD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Zhiwei, Zou, Fan, Wang, Rongli, Wang, Lijun, Cheng, Feiyan, Wang, Lihui, Pan, Rumeng, Guan, Xin, Zheng, Nini, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523704/ https://www.ncbi.nlm.nih.gov/pubmed/37759234 http://dx.doi.org/10.1186/s12957-023-03187-3

Ejemplares similares

Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
por: Cui, Zhiwei, et al.
Publicado: (2022)

FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy
por: Wang, Rongli, et al.
Publicado: (2022)

FGF2 Rescued Cisplatin-Injured Granulosa Cells through the NRF2-Autophagy Pathway
por: Wang, Lihui, et al.
Publicado: (2023)

FTO protects human granulosa cells from chemotherapy-induced cytotoxicity
por: Wang, Rongli, et al.
Publicado: (2022)

WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2020)

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
por: Cui, Zhiwei, et al.
Publicado: (2023)

WDHD1 modulates the post-transcriptional step of the centromeric silencing pathway
por: Hsieh, Chia-Ling, et al.
Publicado: (2011)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2021)

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
por: Deng, Xinna, et al.
Publicado: (2023)

STAT3 plays an important role in DNA replication by turning on WDHD1
por: Zhou, Yunying, et al.
Publicado: (2021)

WDHD1 is over‐expressed in nasopharyngeal carcinoma and may control the expression of ITGAV
por: Wu, Ji‐Yun, et al.
Publicado: (2022)

WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
por: Gong, Lian, et al.
Publicado: (2020)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

WDHD1 facilitates G1 checkpoint abrogation in HPV E7 expressing cells by modulating GCN5
por: Zhou, Yunying, et al.
Publicado: (2020)

World Digestive Health Day – WDHD Poland 2017 Inflammatory Bowel Diseases – Challenges and Hopes
por: Marlicz, Wojciech
Publicado: (2018)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

Bioinformatic analysis of m6A “reader” YTH family in pan-cancer as a clinical prognosis biomarker
por: Li, Lin, et al.
Publicado: (2023)

Chromatin remodelers HELLS, WDHD1 and BAZ1A are dynamically expressed during mouse spermatogenesis
por: Prakash Yadav, Ram, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway
por: Xian, Qingying, et al.
Publicado: (2022)

KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study
por: Sun, Fei, et al.
Publicado: (2022)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
por: Wang, Yuqi, et al.
Publicado: (2023)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_euips7fna8cqjvad3ohtoqouli